Skip to content


Cerezyme (imiglucerase) is an enzyme pharmaceutical. Imiglucerase was first approved as Cerezyme on 1994-05-23. It is used to treat gaucher disease, liver diseases, and splenic diseases in the USA. It has been approved in Europe to treat gaucher disease.
Trade Name Cerezyme
Common Name Imiglucerase
Indication gaucher disease, liver diseases, splenic diseases
Drug Class Enzymes
Get full access now